{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:59:29Z","timestamp":1788011969194,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the last forty years therapy outcomes for depression have remained the same with approximately 50% of patients responding to treatments. Advances are urgently required. We hypothesised that a recent treatment, metacognitive therapy (MCT), might be more effective, by targeting mental control processes that directly contribute to depression. We assessed the clinical efficacy of MCT compared to current best psychotherapy practice, CBT, in adults with major depressive disorder. A parallel randomized single-blind trial was conducted in a primary care outpatient setting. This trial is registered with the ISCRTN registry, number ISRCTN82799488. In total 174 adults aged 18 years or older meeting Diagnostic and Statistical Manual of Mental Disorders IV criteria for major depressive disorder were eligible and consented to take part. 85 were randomly allocated to MCT and 89 to CBT. Randomisation was performed independently following pre-treatment assessment and was stratified for severity of depression (low\u2009&lt;\u200920 vs high\u2009&gt;\u2009=20) on the Hamilton Depression Rating Scale (HDRS) and on sex (male\/female). Assessors and trial statisticians were blind to treatment allocation. Each treatment arm consisted of up to 24 sessions of up to 60\u2009minutes each, delivered by trained clinical psychologists. The co-primary outcome measures were assessor rated symptom severity on the HDRS and self-reported symptom severity on the Beck Depression Inventory II (BDI-II) at post treatment. Secondary outcomes were scores six months post treatment on these measures and a range of symptom and mechanism variables. A key trial design feature was that each treatment was implemented to maximize individual patient benefit; hence time under therapy and number of sessions delivered could vary. Treated groups in the trial were very similar on most baseline characteristics. Data were analyzed on the basis of intention to treat (ITT). No differences were found on the HDRS at post treatment or follow-up (\u22120.95 [\u22122.88 to 0.98], p\u2009=\u20090.336; and \u22121.61 [\u22123.65 to 0.43], p\u2009=\u20090.122), but floor effects on this outcome were high. However, a significant difference favouring MCT was found on the BDI-II at post treatment (\u22125.49 [95% CI \u22128.90 to \u22122.08], p\u2009=\u20090.002), which was maintained at six-month follow-up (\u22124.64 [\u22128.21 to \u22121.06], p\u2009=\u20090.011). Following MCT 74% of patients compared with 52% in CBT met formal criteria for recovery on the BDI-II at post treatment (odds-ratio=2.42 [1.20 to 4.92], p\u2009=\u20090.014). At follow-up the proportions were 74% compared to 56% recovery (odds-ratio=2.19 [1.05 to 4.54], p\u2009=\u20090.036). Significant differences favouring MCT, also maintained over time, were observed for most secondary outcomes. The results were robust against controlling for time under therapy and when outcomes were assessed at a common 90 day mid-term time-point. Limitations of the study include the use of only two therapists where one treated 69% of patients, possible allegiance effects as the study was conducted in an established CBT clinic and the chief investigator is the originator of MCT and group differences in time under therapy. Never the less evidence from this study suggests that MCT had considerable beneficial effects in treating depression that may exceed CBT.<\/jats:p>","DOI":"10.1038\/s41598-020-64577-1","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T06:05:02Z","timestamp":1589263502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial"],"prefix":"10.1038","volume":"10","author":[{"given":"Pia","family":"Callesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Heal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7713-1592","authenticated-orcid":false,"given":"Adrian","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"64577_CR1","doi-asserted-by":"publisher","first-page":"e1001547","DOI":"10.1371\/journal.pmed.1001547","volume":"10","author":"AJ Ferrari","year":"2013","unstructured":"Ferrari, A. J. et al. Burden of depressive disorders by country, sex, age and year: findings from the global burden of disease study. PLos Med. 10, e1001547 (2013).","journal-title":"PLos Med."},{"key":"64577_CR2","doi-asserted-by":"publisher","unstructured":"van Hees, M. L. J., Rotter, T., Ellerman, T. & Evers, S. M. A. The effectiveness of individual interpersonal psychotherapy as a treatment for major depressive disorder in adult outpatients: a systematic review. BMC Psychiatry. 13, https:\/\/doi.org\/10.1186\/1471-244x-13-22 (2013).","DOI":"10.1186\/1471-244x-13-22"},{"key":"64577_CR3","doi-asserted-by":"publisher","first-page":"h6019","DOI":"10.1136\/bmj.h6019","volume":"351","author":"HR Amick","year":"2015","unstructured":"Amick, H. R. et al. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-anlysis. BMJ. 351, h6019 (2015).","journal-title":"BMJ."},{"key":"64577_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1037\/0022-006X.75.3.475","volume":"75","author":"JR Vittengle","year":"2007","unstructured":"Vittengle, J. R., Clark, L. A., Dunn, T. W. & Jarrett, R. B. Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive therapy\u2019s effects. J. Consult Clin Psychol. 75, 475\u2013488 (2007).","journal-title":"J. Consult Clin Psychol."},{"key":"64577_CR5","doi-asserted-by":"crossref","unstructured":"Jarrett, R. B. & Vittengle, J. R. The efficacy of cognitive behavioural therapy for depression. In Wells A, Fisher PL (eds), Treating depression: MCT, CBT and Third Wave Therapies. Chichester: John Wiley & Sons (2016).","DOI":"10.1002\/9781119114482.ch3"},{"key":"64577_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1037\/0022-006X.74.4.658","volume":"74","author":"S Dimidjian","year":"2006","unstructured":"Dimidjian, S. et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J. Consult Clin Psychol. 74, 658\u2013670 (2006).","journal-title":"J. Consult Clin Psychol."},{"key":"64577_CR7","doi-asserted-by":"publisher","unstructured":"Johnsen, T. J. & Friborg, O. The effects of cognitive behavioral therapy as an anti-depressive treatment is falling: A meta-analysis. Psych Bul., https:\/\/doi.org\/10.1037\/bul0000015 (2015).","DOI":"10.1037\/bul0000015"},{"key":"64577_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1037\/0022-006X.72.1.31","volume":"72","author":"SH Ma","year":"2004","unstructured":"Ma, S. H. & Teasdale, J. D. Mindfulness-based cognitive therapy for depression: Replictaion and exploration of differential relapse prevention effects. J. Consult Clin Psychol 72, 31\u201340 (2004).","journal-title":"J. Consult Clin Psychol"},{"key":"64577_CR9","unstructured":"Wells, A. Metacognitive therapy for anxiety and depression. New York: Guilford Press (2009)."},{"key":"64577_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10608-007-9178-2","volume":"33","author":"A Wells","year":"2009","unstructured":"Wells, A. et al. Metacognitive therapy in recurrent and persistent depression: A multiple-baseline study of a new treatment. Cogn Ther Res 33, 291\u2013300 (2009).","journal-title":"Cogn Ther Res"},{"key":"64577_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.brat.2012.02.004","volume":"50","author":"A Wells","year":"2012","unstructured":"Wells, A. et al. Metacognitive therapy in treatment-resistant depression: A platform trial. Beh Res Ther 50, 367\u2013373 (2012).","journal-title":"Beh Res Ther"},{"key":"64577_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10608-014-9632-x","volume":"39","author":"C Papageorgiou","year":"2015","unstructured":"Papageorgiou, C. & Wells, A. Group metacognitive therapy for severe antidepressant and CBT resistant depression: A baseline-controlled trial. Cogn Ther Res 39, 14\u201322 (2015).","journal-title":"Cogn Ther Res"},{"key":"64577_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3109\/08039488.2014.936502","volume":"69","author":"T Dammen","year":"2015","unstructured":"Dammen, T., Papapgeorgiou, C. & Wells, A. An open trial of group metacognitive thetrapy for depression in Norway. Nord J. Psychiatry 69, 126\u2013131 (2015).","journal-title":"Nord J. Psychiatry"},{"key":"64577_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fpsyg.2017.00031","volume":"8","author":"R Hagen","year":"2017","unstructured":"Hagen, R. et al. Metacognitive therapy for depression in adults: A waiting list randomized controlled trial with six months follow-up. Front Psychol 8, 31 (2017).","journal-title":"Front Psychol"},{"key":"64577_CR15","unstructured":"Jordan, J. et al. Metacognitive therapy versus cognitive behavioural therapy for depression: A randomized pilot study. Aust N Z J. Psychiatry 201416"},{"key":"64577_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/da.22341","volume":"32","author":"SJ Groves","year":"2015","unstructured":"Groves, S. J. et al. Changes in neuropsychological function after treatment with metacognitive therapy or cognitive behaviour therapy for depression. Depress Anxiety. 32, 437\u2013444 (2015).","journal-title":"Depress Anxiety."},{"key":"64577_CR17","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3389\/fpsyg.2018.02211","volume":"9","author":"N Normann","year":"2018","unstructured":"Normann, N. & Morina, N. The efficacy of metacognitive therapy: A systematic review and meta-analysis. Front.Psychol 9, 2211, https:\/\/doi.org\/10.3389\/fpsyg.2018.02211 (2018).","journal-title":"Front.Psychol"},{"key":"64577_CR18","unstructured":"Beck, A. T., Rush, A. J., Shaw, B. F. & Emery, G. Cognitive Therapy of Depression. New York: Guilford Press (1979)."},{"key":"64577_CR19","doi-asserted-by":"crossref","unstructured":"Fennel, M. J. V. Depression in Cognitive Behaviour Therapy for Psychiatric Problems: A Practical Guide (eds. Hawton, K., Salkovskis, P. M., Kirk, J. & Clark, D. M.) 169\u2013234 (Oxford University Press, 1989).","DOI":"10.1093\/med:psych\/9780192615879.003.0006"},{"key":"64577_CR20","unstructured":"Beck, A. T. & Greenberg, R. L. Coping with Depression. (New York: Institute of Rational Emotive Therapy, 1974)."},{"key":"64577_CR21","unstructured":"Beck, A. T., Steer, R. A. & Brown, G. K. Manual for the BDI-II. (San Antonio: Psychological Corporation, 1996)."},{"key":"64577_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton, M. A rating scale for depression. J. Neurol Neurosur Psychiatry 23, 56\u201362 (1960).","journal-title":"J. Neurol Neurosur Psychiatry"},{"key":"64577_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck, A. T., Epstein, N., Brown, G. & Steer, R. A. An inventory for measuring clinical anxiety: Psychometric properties. J. Consult Clin Psychol. 56, 893\u2013897 (1988).","journal-title":"J. Consult Clin Psychol."},{"key":"64577_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0005-7967(03)00147-5","volume":"42","author":"A Wells","year":"2004","unstructured":"Wells, A. & Cartwright-Hatton, S. A short form of the metacognitions questionnaire: Properties of the MCQ30. Beh Res Ther 42, 385\u201396 (2004).","journal-title":"Beh Res Ther"},{"key":"64577_CR25","unstructured":"Papageorgiou, C. & Wells, A. The negative beliefs about rumination scale in Depression, Rumination and Metacognition: Empirical Tests of an Information Processing Model (Papageorgiou, C) PhD Thesis, (University of Manchester, 2004)."},{"key":"64577_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0005-7894(01)80041-1","volume":"32","author":"C Papageorgiou","year":"2002","unstructured":"Papageorgiou, C. & Wells, A. Positive beliefs about depressive rumination: Development and preliminary validation of a self-report scale. Beh Ther 32, 13\u201326 (2002).","journal-title":"Beh Ther"},{"key":"64577_CR27","first-page":"1389","volume":"40","author":"MM Weissman","year":"1979","unstructured":"Weissman, M. M. & Beck, A. T. The dysfunctional attitudes scale: A validation study. Dissertations Abstracts International 40, 1389\u201390B (1979).","journal-title":"Dissertations Abstracts International"},{"key":"64577_CR28","doi-asserted-by":"crossref","unstructured":"Young, J. E. The Young Schema Questionnaire Short Form. New York: Cognitive Therapy Centre (1998).","DOI":"10.1037\/t12644-000"},{"key":"64577_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1037\/0022-006X.59.1.12","volume":"59","author":"NS Jacobson","year":"1991","unstructured":"Jacobson, N. S. & Truax, P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J. Consult Clin Psychol 59, 12\u201319 (1991).","journal-title":"J. Consult Clin Psychol"},{"key":"64577_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1037\/0022-0167.36.2.223","volume":"36","author":"AO Horvath","year":"1989","unstructured":"Horvath, A. O. & Greenberg, L. S. Development and validation of the Working Alliance Inventory. J. Couns Psychol. 36, 223\u2013233 (1989).","journal-title":"J. Couns Psychol."},{"key":"64577_CR31","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1176\/appi.ajp.161.12.2163","volume":"161","author":"RM Bagby","year":"2004","unstructured":"Bagby, R. M., Ryder, A. G., Schuller, D. R. & Marshall, M. B. The Hamilton Depression Rating Scale: Has the gold standard become a lead weight? Am J. Psychiatry. 161, 2163\u20132177 (2004).","journal-title":"Am J. Psychiatry."},{"key":"64577_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.brat.2009.01.003","volume":"47","author":"S Solem","year":"2009","unstructured":"Solem, S., Haland, A. T., Vogel, P. A., Hansen, B. & Wells, A. Change in metacognitions predicts outcome in obsessive-compulsive disorder patients undergoing treatment with exposure and response prevention. Beh Res Ther 47, 301\u2013307 (2009).","journal-title":"Beh Res Ther"},{"key":"64577_CR33","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.3389\/fpsyg.2019.02621","volume":"10","author":"A Wells","year":"2019","unstructured":"Wells, A. Breaking the cybernetic code: Understanding and treating the human metacognitive control system to enhance mental health. Front Psychol 10, 2621, https:\/\/doi.org\/10.3389\/fpsyg.2019.02621 (2019).","journal-title":"Front Psychol"}],"updated-by":[{"DOI":"10.1038\/s41598-020-68559-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64577-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64577-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64577-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:02:27Z","timestamp":1670302947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64577-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["64577"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-64577-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"16 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no support from any organisation for the submitted work. AW declares he is director of MCT Institute and provides lectures on MCT and CBT. All other authors declare no other competing financial or non-financial interests. This study was unfunded.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7878"}}